Using molecular markers in sputum for the early detection of lung cancer: A review

Timothy C. Kennedy, Fred R. Hirsch

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Recent exciting advances have been made in identifying potential molecular markers in sputum which may soon be ready for validation trials to indicate high risk for lung cancer, especially central airway squamous cell lung cancer. Hopefully, a set of biomarkers will be identified with higher sensitivity, specificity, and enough lead-time compared to traditional cytopathology to justify endobronchial evaluation and local therapy to help reduce lung-cancer mortality in high-risk patients.

Original languageEnglish
Pages (from-to)S21-S27
JournalLung Cancer
Volume45
Issue numberSUPPL. 2
DOIs
StatePublished - Aug 2004
Externally publishedYes

Keywords

  • Biological markers
  • Non-small-cell lung carcinoma
  • Sputum

Fingerprint

Dive into the research topics of 'Using molecular markers in sputum for the early detection of lung cancer: A review'. Together they form a unique fingerprint.

Cite this